J&J Forecasts Strong Pharma Growth In 2021, But No COVID-19 Vaccine Update
Data from a high-profile Phase III COVID-19 vaccine trial will be released the first week of February, management said.
Data from a high-profile Phase III COVID-19 vaccine trial will be released the first week of February, management said.